Company profile: Flosonics Medical
1.1 - Company Overview
Company description
- Provider of non-invasive sensors to improve management of critically ill patients, including FloPatch, a wireless wearable Doppler ultrasound smart-bandage for real-time hemodynamic assessment and fluid management. Offers FloPatch App to display real-time arterial blood velocity and Doppler metrics to support clinical decisions on fluid responsiveness.
Products and services
- FloPatch App: Flosonics develops a real-time application displaying arterial blood velocity and Doppler metrics to support clinical decisions on fluid responsiveness for critically ill patient management
- FloPatch: Flosonics engineers FloPatch, a smart-bandage wireless wearable Doppler ultrasound device enabling real-time hemodynamic assessments and fluid management guidance for critically ill patients, supporting physicians, nurses, and paramedics in ambulances
- Non-Invasive Sensor Development: Flosonics architects non-invasive sensor development to improve management of critically ill patients, addressing unmet clinical needs for physicians, nurses, and paramedics caring for them in ambulances
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Flosonics Medical
VerAvanti
HQ: United States
Website
- Description: Provider of single-use intravascular endoscopic technologies, including a Scanning Fiber Endoscope delivering real-time, high-resolution images of intravascular anatomy to help diagnose and treat stroke and cardiovascular events; in-house MEMS manufacturing of micro-small components using precise robotics and cleanroom assembly; and O-pH imaging to measure oral biofilm acidity to predict and manage tooth decay.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full VerAvanti company profile →
CryoTherapeutics
HQ: Belgium
Website
- Description: Provider of a proprietary intracoronary cryotherapy system (CTS) for the treatment of coronary artery disease, designed to stabilize high-risk plaque lesions and potentially prevent heart attacks without leaving a stent. Offerings include a patented catheter and console interface for localized cryoenergy delivery, and ongoing clinical trials, including the POLARSTAR study, to demonstrate safety and efficacy for regulatory approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CryoTherapeutics company profile →
Micell Technologies
HQ: United States
Website
- Description: Provider of biomedical device solutions focused on developing interventional cardiology systems for vascular drug delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Micell Technologies company profile →
CorWave
HQ: France
Website
- Description: Provider of biomimetic heart pumps and cardiac support devices, including the CorWave LVAD for advanced heart failure that uses an undulating disc wave mechanism to deliver pulsatile, physiological blood flow with less blood trauma, reducing clotting and bleeding complications; Nemo, a compact, minimally invasive device for partial heart failure support; and Wave Membrane Technology enabling physiological flow and pulsatility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CorWave company profile →
Ash Access Technology
HQ: United States
Website
- Description: Provider of technologies and devices to treat and prevent the clinical consequences of vascular access-related diseases, including central line hemodialysis catheters designed to prevent fibrous sheaths, split-tip dialysis catheters, 7% sodium citrate catheter lock solutions, an extracorporeal charcoal-based sorbent liver dialysis system, and skin prep for vascular access procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ash Access Technology company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Flosonics Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Flosonics Medical
2.2 - Growth funds investing in similar companies to Flosonics Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Flosonics Medical
4.2 - Public trading comparable groups for Flosonics Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →